Kerberos Proximal Solutions Inc.
Kerberos Proximal Solutions Inc., was founded to develop a proximal embolic-protection technology to recover debris dislodged during angioplasty and stent placement. Kerberos launched its lead product for coronary and peripheral use under the Rinspiration System™.
FoxHollow Technologies (Nasdaq: FOXH) acquired Kerberos for $13 million and up to an additional $19 million in future milestones.
Investors
- Research Corporation Technoologies, Inc.
- Boston Scientific
Inventors/Founders
- John MacMahon, President, Chief Executive Officer
- Thomas Goff, Chief Design Engineer